Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Human Reproduction Update

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/humupd/dms059PMID 23303572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome

  2013cited by this paper
• Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS

  2012cited by this paper
• Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome.

  2012cited by this paper
• Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.

  2012influential reference
• Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.

  2012cited by this paper
• Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction

  2012influential reference
• Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset

  2012cited by this paper
• Association of thrombophilia and polycystic ovarian syndrome in women with history of recurrent pregnancy loss

  2012cited by this paper
• Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome

  2012influential reference
• Effect of Lifestyle Modification and Metformin Therapy on Emerging Cardiovascular Risk Factors in Overweight Indian Women with Polycystic Ovary Syndrome

  2012cited by this paper
• Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome

  2011cited by this paper
• Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

  2011cited by this paper
• Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance.

  2011influential reference
• Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome

  2011influential reference
• Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D.

  2011cited by this paper
• Different responses to oxidized low-density lipoproteins in human polarized macrophages

  2011cited by this paper
• Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome

  2011influential reference
• Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment

  2011influential reference
• Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance.

  2011cited by this paper
• Antioxidants Induce Apoptosis of Rat Ovarian Theca-Interstitial Cells1

  2011cited by this paper
• Vascular function in the diagnostic categories of polycystic ovary syndrome.

  2011cited by this paper
• Insulin Resistance in Non-Obese Subjects Is Associated with Activation of the JNK Pathway and Impaired Insulin Signaling in Skeletal Muscle

  2011cited by this paper
• Periodontal disease in polycystic ovary syndrome.

  2011cited by this paper
• High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome

  2011cited by this paper
• Evaluation of Homocysteine Levels in Patients with Polycystic Ovarian Syndrome

  2011cited by this paper
• Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

  2011cited by this paper
• Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.

  2011influential reference
• Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: A pilot study

  2011cited by this paper
• Homocysteine and ghrelin link with polcystic ovary syndrome in relation to obesity.

  2011cited by this paper
• A possible role for familial thrombophilia in women with polycystic ovarian syndrome

  2011cited by this paper
• Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered

  2011influential reference
• Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.

  2011influential reference
• Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.

  2011cited by this paper
• Role of Oxidative Stress in Polycystic Ovary Syndrome

  2010cited by this paper
• Androgen Excess Produces Systemic Oxidative Stress and Predisposes to β-Cell Failure in Female Mice

  2010cited by this paper
• Cardiovascular risk factors in polycystic ovary syndrome

  2010cited by this paper
• Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.

  2010cited by this paper
• Serum High-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy in Women With Polycystic Ovary Syndrome: A Prospective, Matched Study

  2010cited by this paper
• Changes in Oxidative Stress and Insulin Resistance in Morbidly Obese Patients After Bariatric Surgery

  2010cited by this paper
• Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients

  2010cited by this paper
• The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

  2010cited by this paper
• Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome.

  2010influential reference
• Effects of Controlled-Release Alpha Lipoic Acid in Lean, Nondiabetic Patients with Polycystic Ovary Syndrome

  2010cited by this paper
• Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.

  2010cited by this paper
• The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPK Pathways*

  2010cited by this paper
• Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome.

  2010cited by this paper
• Comparison Of The Effects Of Atorvastatin And Simvastatin In Women With Polycystic Ovary Syndrome: A Prospective, Randomized Study

  2010cited by this paper
• Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.

  2010cited by this paper
• Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine

  2010influential reference
• Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.

  2010cited by this paper
• Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome

  2010cited by this paper
• Serum nonesterified fatty acids, ghrelin, and homocysteine levels in women with polycystic ovary syndrome

  2010cited by this paper
• Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters.

  2010influential reference
• l-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: a prospective, placebo controlled, randomised, pilot study

  2010cited by this paper
• Methylenetetrahydrofolate reductase C677T gene polymorphism in turkish patients with polycystic ovary syndrome

  2010cited by this paper
• Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.

  2010cited by this paper
• C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome.

  2010cited by this paper
• Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome.

  2010cited by this paper
• Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome

  2010cited by this paper
• Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women.

  2010influential reference
• A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.

  2009cited by this paper
• Homocysteine concentrations in follicular fluid are associated with poor oocyte and embryo qualities in polycystic ovary syndrome patients undergoing assisted reproduction.

  2009influential reference
• How to select, calculate, and interpret effect sizes.

  2009cited by this paper
• The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.

  2009cited by this paper
• Effects of Metformin With or Without Supplementation With Folate on Homocysteine Levels and Vascular Endothelium of Women With Polycystic Ovary Syndrome

  2009cited by this paper
• Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS.

  2009cited by this paper
• Effect of Follicular Fluid Oxidative Stress on Meiotic Spindle Formation in Infertile Women with Polycystic Ovarian Syndrome

  2009cited by this paper
• Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?

  2009cited by this paper
• Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.

  2009cited by this paper
• Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome.

  2009cited by this paper
• Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.

  2009cited by this paper
• Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study.

  2009cited by this paper
• Lipid peroxidation, glutathione, ascorbic acid, vitamin E, antioxidant enzyme and serum homocysteine status in patients with polycystic ovary syndrome

  2009influential reference
• Oxidative stress but not endothelial dysfunction exists in non‐obese, young group of patients with polycystic ovary syndrome

  2009cited by this paper
• Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance.

  2009cited by this paper
• Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome

  2009cited by this paper
• The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

  2009cited by this paper
• Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.

  2009influential reference
• Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome

  2009cited by this paper
• The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.

  2008cited by this paper
• Vascular Risk in Young Women With Polycystic Ovary and Polycystic Ovary Syndrome

  2008cited by this paper
• Plasma homocysteine concentrations and the single nucleotide polymorphisms in the methionine synthase gene (MTR 2756A>G): Associations with the polycystic ovary syndrome An observational study.

  2008cited by this paper
• Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).

  2008cited by this paper
• Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance.

  2008cited by this paper
• Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.

  2008influential reference
• The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients

  2008influential reference
• Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey

  2008cited by this paper
• Oxidative Stress in Nonobese Women with Polycystic Ovary Syndrome: Correlations with Endocrine and Screening Parameters

  2008cited by this paper
• Serum Levels of Leptin and Homocysteine in Women with Polycystic Ovary Syndrome and Its Relationship to Endocrine, Clinical and Metabolic Parameters

  2008cited by this paper
• Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.

  2008cited by this paper
• Effect of folic acid in women with and without insulin resistance who have hyperhomocysteinemic polycystic ovary syndrome

  2008cited by this paper
• Oxidative Stress Markers in Young Patients with Polycystic Ovary Syndrome, The Relationship between Insulin Resistances

  2008cited by this paper
• The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.

  2008cited by this paper
• The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome

  2008cited by this paper
• The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome

  2007cited by this paper
• Prospective, randomized trial of metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary syndrome.

  2007cited by this paper
• Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate-resistant polycystic ovary syndrome.

  2007cited by this paper
• Plasma homocysteine and polycystic ovary syndrome: the missed link.

  2007cited by this paper
• Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome

  2007cited by this paper

• Therapeutic mechanisms of metformin and Bushen Ditan Decoction in polycystic ovary syndrome: Evidence from a rat model and miRNA sequencing

  2026cites this paper
• Increased DNA and oxidative damage in PCOS: effect of elevated androgens

  2026cites this paper
• Beyond Metformin: A Review of Non-pharmacological Treatments for Polycystic Ovary Syndrome

  2026cites this paper
• The pathogenesis, therapeutic targets and drugs of polycystic ovary syndrome

  2026cites this paper
• Date palm pollen extract improves fertility and pregnancy outcomes in letrozole-induced polycystic ovary syndrome rats

  2026cites this paper
• Elevated maternal pre-transfer serum lipid peroxidation is associated with implantation failure and early pregnancy loss

  2026cites this paper
• Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms

  2026cites this paper
• Nutrients and bioactive compounds in polycystic ovary syndrome: updated insights into effects and underlying mechanisms.

  2026cites this paper
• Elevated homocysteine levels predict impaired liver and renal function in women of reproductive age with polycystic ovary syndrome: a post-hoc analysis of a randomized controlled trial

  2026cites this paper
• The Combinatory Effect of Salvia officinalis and Nigella sativa Extracts on Polycystic Ovarian Syndrome Induced in Mice

  2026cites this paper
• Biomarkers for effective prognosis of polycystic ovary syndrome: a full review.

  2026cites this paper
• Kaempferol ameliorates PCOS by alleviating metabolic and endocrine abnormalities as well as oxidative stress.

  2026cites this paper
• The possible regulatory role of miRNA-30c-5p, miRNA-545-3p and miRNA-125a-5p in women with Polycystic Ovary Syndrome: a case-control study and signaling pathways.

  2025cites this paper
• Journey through the gut-inflammation axis in polycystic ovary syndrome: the microbiota's role in shaping inflammatory pathways.

  2025cites this paper
• Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking

  2025cites this paper
• The Role of Mitochondrial Dysfunction and Oxidative Stress in Women’s Reproductive Disorders: Implications for Polycystic Ovary Syndrome and Preeclampsia

  2025cites this paper
• Gingival Inflammation Modulates NLRP3 Inflammasome Signalling in Peripheral Blood Mononuclear Cells of PCOS Patients: A Case-Control Study

  2025cites this paper
• Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome – a randomized placebo-controlled clinical trial

  2025cites this paper
• Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome

  2025cites this paper
• Fundamental mechanisms of cell death for polycystic ovary syndrome

  2025cites this paper
• Polycystic Ovary Syndrome in Medical Students: A Cross-Sectional Study of the Academic and Psychosocial Impact

  2025cites this paper
• Multitargeted Effects of Plantago ovata Ethanol Extract in Experimental Rat Streptozotocin-Induced Diabetes Mellitus and Letrozole-Induced Polycystic Ovary Syndrome

  2025cites this paper
• Cardiovascular Consequences of Premature Menopause

  2025cites this paper
• Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome.

  2025cites this paper
• Prevalence and Levels of Thyroid Autoantibodies in Polycystic Ovary Syndrome—Impact of TSH- and BMI-Matched Comparisons: A Systematic Review and Meta-Analysis

  2025cites this paper
• association between serum leptin levels and body mass index in polycystic ovarian syndrome patients

  2025cites this paper
• Deciphering the interplay between oxidative stress and inflammation in polycystic ovary syndrome: outcome of a case-control study

  2025cites this paper
• Inhibition of 14-3-3 Protein Enhances Steroid Hormone Production and Oxidative Stress in Mouse Ovary: Implications for Apoptosis Regulation.

  2025cites this paper
• Antinuclear Antibodies in Polycystic Ovary Syndrome: A Systematic Review of Observational Studies

  2025cites this paper
• Empagliflozin Improves Follicular Development by Attenuating Oxidative Stress and Inflammation in a Mouse Model of Polycystic Ovary Syndrome

  2025cites this paper
• Therapeutic effects of chromium supplementation on women with polycystic ovarian syndrome: A systematic review and meta-analysis.

  2025cites this paper
• Therapeutic potential of Phoenix dactylifera pulp and seed extracts in mitigating oxidative stress and organ dysfunction in testosterone-induced polycystic ovary syndrome

  2025cites this paper
• Semaglutide Alleviates Ovarian Oxidative Stress and Autophagy via the PI3K/AKT/mTOR Pathway in Mice with Polycystic Ovary Syndrome

  2025cites this paper
• Targeting Polycystic Ovary Syndrome (PCOS) Pathophysiology with Flavonoids: From Adipokine–Cytokine Crosstalk to Insulin Resistance and Reproductive Dysfunctions

  2025cites this paper
• Shortened Relative Leukocyte Telomere Length Is Associated With Polycystic Ovary Syndrome and Metabolic Traits

  2025cites this paper
• Empagliflozin as a potential therapy for PCOS: Restoring hormonal balance and ovarian function in a letrozole-induced rat model.

  2025cites this paper
• Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation

  2025cites this paper
• Polycystic Ovarian Syndrome: A Review of Multi-omics Analyses

  2025cites this paper
• Effect of Maca root (Lepidium meyenii) on some biochemical and antioxidant parameters in rats with experimental polycystic ovary syndrome

  2025cites this paper
• The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications—A Narrative Review

  2025cites this paper
• GPX4 deficiency-induced ferroptosis drives endometrial epithelial fibrosis in polycystic ovary syndrome

  2025cites this paper
• Evaluating the Impact of rs4025935, rs71748309, rs699947, and rs4646994 Genetic Determinants on Polycystic Ovary Syndrome Predisposition—A Case-Control Study

  2025cites this paper
• Effect of Exercise and Nutrition on Oxidative Stress in Females with Polycystic Ovary Syndrome, a Current Status and Future Perspective in Narrative Review

  2025cites this paper
• Trimethylamine N-oxide Supplementation Enhances the Quality of Oocytes in Mice of Polycystic Ovary Syndrome.

  2025cites this paper
• Homocysteine and Multiple Health Outcomes: An Outcome-Wide Umbrella Review of Meta-analyses and Mendelian Randomization Studies

  2025cites this paper
• Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions.

  2025cites this paper
• Delving into the Therapeutic Prospects of Desmostachya Bipinnata (L.) in the Context of Polycystic Ovary Syndrome (PCOS): A Comprehensive Review

  2025cites this paper
• New insights into pentoxifylline and α-lipoic acid: Co-administration with clomiphene citrate for ovulation induction in anovulatory women with polycystic ovary syndrome.

  2025cites this paper
• Understanding the Impact of Stress on Infertility: Biological Links and Treatment Strategies

  2025cites this paper
• Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation

  2025cites this paper
• Protective Effects of Nutritional and Polyphenolic Supplementation in Polycystic Ovarian Syndromes

  2025cites this paper
• Correlation between adiponectin levels, insulin resistance, and oxidative stress in polycystic ovary syndrome patients: implications for novel therapeutic approaches

  2025cites this paper
• Therapeutic targets of L-carnitine against polycystic ovary syndrome and the underlying signaling mechanisms

  2025cites this paper
• Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities

  2025cites this paper
• An Insight into Experimental Animal Models for Polycystic Ovarian Syndrome and Associated Disorders

  2025cites this paper
• Therapeutic efficacy of Rosa damascena Mill. on oxidative stress parameters and cyclooxygenase-2 gene expression in estradiol valerate-induced polycystic ovarian syndrome in Wistar rats

  2025cites this paper
• Beneficial Role of Resveratrol on Oxidative Stress in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial

  2025cites this paper
• Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets.

  2025cites this paper
• Exploration of key genes associated with oxidative stress in polycystic ovary syndrome and experimental validation

  2025cites this paper
• Unraveling the multifactorial pathophysiology of polycystic ovary syndrome: exploring lifestyle, prenatal influences, neuroendocrine dysfunction, and post-translational modifications

  2025cites this paper
• Gut microbial metabolite indole-3-propionic acid alleviates polycystic ovary syndrome in mice by regulating the AhR-NLRP3 axis.

  2025cites this paper
• Long Noncoding RNA NONHSAT233728.1 Promotes ROS Accumulation and Granulosa Cell Apoptosis by Regulating the MAPK/ERK1/2 Signaling Pathway

  2025cites this paper
• Exploring the role of ferroptosis and lipid metabolism in polycystic ovary syndrome: mechanisms and therapeutic strategies

  2025cites this paper
• Astaxanthin and omega-3 fatty acids enhance endometrial receptivity in a rat model of polycystic ovary syndrome.

  2025cites this paper
• Clinical symptom improvement and lipidomic signatures in overweight/obese PCOS treated by lifestyle and acupuncture intervention

  2025cites this paper
• Single-cell transcriptomics uncovering a critical AKT-LONP1-STAR axis in ovarian hyperandrogenism of PCOS

  2025influential citation
• Apoptosis in polycystic ovary syndrome: Mechanisms and therapeutic implications.

  2025cites this paper
• Genotypic and metabolic impact of the SOD1 I>D polymorphism in polycystic ovary syndrome.

  2025cites this paper
• Nipecotic Acid Ameliorates Letrozole Induced Poly Cystic Ovarian Syndrome in Female Virgin Wistar Rats by Modulating Hypothalamic-Pituitary-Gonadal (HPG) Axis Regulated by GABA

  2025cites this paper
• The Role of the Liver in the Pathophysiology of PCOS: A Literature Review

  2025cites this paper
• Unveiling Therapeutic Potential of Yoga Mitigating Oxidative Stress and Mitochondrial Dysfunction in PCOS: A Randomized Controlled Trial

  2025cites this paper
• Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model

  2025cites this paper
• Gut Microbiota as an Endocrine Organ: Unveiling Its Role in Human Physiology and Health

  2024cites this paper
• Stress and Infertility: Biological Mechanisms and Management

  2024cites this paper
• Assessment of Oxidative Stress Levels in Women with Different Phenotypes of Polycystic Ovary Syndrome and its Correlation with Lipid and Hormonal Profile

  2024cites this paper
• Astaxanthin: a novel antioxidant for polycystic ovary syndrome?

  2024cites this paper
• Serum Selenium Levels and Their Relationship with Insulin Resistance in Individuals with Polycystic Ovary Syndrome

  2024cites this paper
• The Impact of Vitamin D Receptor Gene Polymorphisms (FokI, ApaI, TaqI) in Correlation with Oxidative Stress and Hormonal and Dermatologic Manifestations in Polycystic Ovary Syndrome

  2024cites this paper
• Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic review and meta-analysis of clinical and animal studies

  2024cites this paper
• Biomarkers to inform the management of polycystic ovary syndrome: A review of systematic reviews

  2024influential citation
• 2023 International Evidence‐Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta‐Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome

  2024cites this paper
• A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome

  2024cites this paper
• Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study

  2024cites this paper
• Effects of carvacrol on hormonal, inflammatory, antioxidant changes, and ovarian reserve in polycystic ovary syndrome in Wistar rats

  2024cites this paper
• Effects of vitamin D supplementation on oxidative stress biomarkers of Iranian women with polycystic ovary syndrome: a meta-analysis study

  2024cites this paper
• Novel therapeutic insights of Alpha lipoic acid: antioxidant, and steroidogenesis regulatory role in letrozole induced PCOS rat model

  2024cites this paper
• The beneficial influences of vitamin D intake on inflammation and oxidative stress in infertile women with polycystic ovary syndrome

  2024cites this paper
• The Concentration of Follistatin and Activin A in Serum and Selected Biochemical Parameters in Women with Polycystic Ovary Syndrome: Stratification by Tobacco Smoke Exposure, Insulin Resistance, and Overweight/Obesity

  2024cites this paper
• Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways

  2024cites this paper
• Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome

  2024cites this paper
• Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome

  2024cites this paper
• Do Popular Diets Impact Fertility?

  2024cites this paper
• Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome

  2024cites this paper
• SIRT3 protects endometrial receptivity in patients with polycystic ovary syndrome

  2024cites this paper
• Causal Relationships between Homocysteine and the Polycystic Ovary Syndrome: A Mendelian Randomization Analysis

  2024cites this paper
• Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics

  2024cites this paper
• Evaluation of folliculogenesis and oxidative stress parameters in type 1 diabetes mellitus women with different glycemic profiles

  2024cites this paper
• A cross talk study on sitagliptin mediated reclamation on TGF β signalling, DPP 4, miR-29a and miR-24 expression in PCOS rats fed with high fat-high fructose diet.

  2024cites this paper
• Bibliometric and visual analysis on oxidative stress in gynecological and reproductive diseases: A systematic review

  2024cites this paper
• A Randomized Trial of the Efficacy of Three Weight Loss Diet Interventions in Overweight/Obese with Polycystic Ovary Syndrome.

  2024cites this paper